Pradaxa Lawsuit News and Information

feature photo

Pradaxa Internal Bleeding Lawsuit

The new blood thinner Pradaxa has been linked to an increased risk of serious and potentially life-threatening bleeding, leading many to question its safety.  PRADAXA LAWSUIT STATUS: Users of Pradaxa who suffered severe internal bleeding, hemorrhages or other problems may be eligible to pursue a Pradaxa lawsuit. Lawyers are reviewing potential claims for individuals throughout […]

Review a potential case with an attorney

All Articles Tagged With: "Pradaxa"

Xarelto Complications Continue to Increase as Use of Medication Grows

A recent report highlights the growing trend in Xarelto injuries and shows how the FDA may be underestimating the side effects of some drugs.

Reversal Agent for Pradaxa Bleeds Given “Breakthrough” Status by FDA

The makers of the blood thinner Pradaxa have received breakthrough status to speed up the development of a potential antidote to prevent Pradaxa bleeding injuries and deaths.

Despite Bleeding Risks with Xarelto, Pradaxa, Greater Use of Drugs Pushed

UK health officials are recommending increased use of Pradaxa and Xarelto, despite the potential bleeding risks.

Xarelto Bleeding Problems Result in Lawsuits Against Bayer, J&J

A growing number of Xarelto lawsuits are being filed over bleeding risks associated with the anticoagulant.

OpenFDA Promises Free, Open Access to Vital Health Data

The FDA has launched a new open-access database for its drug adverse event reports, which it says is the first step in greater transparency.

Pradaxa Settlement Reached to Resolve 4,000 Cases for $650M

The makers of Pradaxa and plaintiffs’ attorneys have reached a $650 million settlement to resolve about 4,000 product liability claims.

Committee of Lawyers Appointed to Negotiate Pradaxa Settlement

A federal judge is trying to get both sides to forge a settlement agreement that could prevent thousands of Pradaxa lawsuits from going to trial.

Pradaxa Makers Admit Leaving Bleeding Incidents Out of Study

Boehringer Ingelheim has found more inconsistencies with the RE-LY trial that led to Pradaxa’s approval, but continues to stand behind the study’s results.

Xarelto Adverse Events Now Outnumber Pradaxa’s: Report

Adverse event reports involving Xarelto over the last year exceed those with Pradaxa, as the drug rises in popularity.

Pradaxa Stomach Bleed Risks Higher Than Warfarin: FDA

The FDA warns that the blood thinner Pradaxa appears more likely to cause gastrointestinal bleeding when compared to warfarin.

  • Contact a Lawyer

    Submit information about your potential case to be reviewed by an attorney.
    1. (required)
    2. (required)
    3. Captcha

    cforms contact form by delicious:days

  • Related Tags